Effectiveness of Gentamicin-Impregnated Cement in the Prevention of Deep Wound Infection After Primary Total Knee Arthroplasty

Infection Control and Hospital Epidemiology

Volumn 24, Issue 10, 2003, Pages 778-780

  Eveillard, Matthieu ^a,b   Mertl, Patrice ^a   Tramier, Blaise ^a   Eb, François ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b HÔPITAL LOUIS MOURIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFAMANDOLE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CORTICOSTEROID; GENTAMICIN BONE CEMENT; OXACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; FEMALE; HUMAN; JOINT PROSTHESIS; KNEE ARTHROPLASTY; KNEE SURGERY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; POSTOPERATIVE INFECTION; TOTAL KNEE REPLACEMENT; TREATMENT OUTCOME; WOUND INFECTION;

ADHESIVES; ANTI-BACTERIAL AGENTS; ARTHROPLASTY, REPLACEMENT, KNEE; DRUG CARRIERS; FEMALE; FRANCE; GENTAMICINS; HUMANS; MALE; SURGICAL WOUND INFECTION;

EID: 0142246212     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502134     Document Type: Article

References (14)

1. Wade M, Baba H, Imura S. Prosthetic knee Candida parapsilosis infection. J Arthroplasty 1998;13:479-482.
2. Segawa H, Tsukayama DT, Kyle RF, Becker DA, Gustilo RP. Infection after total knee arthroplasty. J Bone Joint Surg Am 1999;81:1434-1445.
3. Association of Operating Room Nurses. Recommended practices for skin preparation of patients. AORN J 1996;64:813-816.
4. Hill C, Flamant R, Mazas F, Evrard J. Prophylactic cefazolin vs. placebo in total hip replacement. Lancet 1981;1:795-796.
5. Lidwell OM, Lowbury RJL, Whyte W, Blowers R, Stanley SJ, Lowe D. Effect of ultraclean air in operating rooms on deep sepsis in the joint after total hip or knee replacement: a randomized study. Br Med J 1982;285:10-14.
6. Schutzer SF, Harris WH. Deep wound infection after total hip replacement under contemporary aseptic conditions. J Bone Joint Surg Am 1988;70:724-727.
7. Persson U, Persson M, Malchan H. The economics of preventing revisions in total hip replacement. Acta Orthop Scand 1999;70:163-169.
8. Chiu FY, Chen CM, Lin CF, Lo WH. Cefuroxime-impregnated cement in primary total knee arthroplasty: a prospective randomized study of three hundred and forty knees. J Bone Joint Surg Am 2002;84:759-762.
9. Hanssen AD, Osmon DR. The use of prophylactic antimicrobial agents during and after hip arthroplasty. Clin Orthop 1999;369:124-138.
10. Société Française d'Anesthésie et de Réanimation. Antibioprophylaxie en milieu chirurgical chez l'adulte: conférence de consensus. Ann Fr Anesth Reanim 1992;12:337-354.
11. Société Française d'Anesthésie et de Réanimation. Recommandations pour la pratique de l'antibioprophylaxie en chirurgie: actualisation 1999. Médecine Maladies Infectieuses 1999;29:435-445.
12. Greenfield S. The state of outcome research: are we on target? N Engl J Med 1989;320:1142-1143.
13. Chiu FY, Lin CF, Chen CM, Lo WH, Chaung TY. Cefuroxime-impregnated cement at primary total knee arthroplasty in diabetes mellitus: a prospective, randomised study. J Bone Joint Surg Br 2001;83:691-695.
14. Lelièvre H, Lina G, Jones ME, et al. Emergence and spread in French hospitals of methicillin-resistant Staphylococcus aureus with increasing susceptibility to gentamicin and other antibiotics. J Clin Microbiol 1999;37:3452-3457.